Name: Artificial Intelligence in Drug Discovery Market News
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy

Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, By Application, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Aug 2023

Code : CMI6125

Pages :190

Formats :

Excel and PDF

Industry : Healthcare IT

Market News

Global Artificial Intelligence in Drug Discovery Market: Key Developments

On May 08 2023, Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced it has signed agreements to acquire two companies in the AI-enabled drug discovery space: Cyclica and Valence.
In August 2022, Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, announced that it has established a strategic and exclusive research collaboration with Sanofi that will leverage its AtomNet platform for computational discovery and research of up to five drug targets.